tert-butyl (2-(6-bromopyridin-3-yl)propan-2-yl)carbamate | 850197-51-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: tert-butyl (2-(6-bromopyridin-3-yl)propan-2-yl)carbamate
• 英文别名: 2-bromo-5-(1-tert-butoxycarbonylamino-1-methylethyl)-pyridine；Tert-butyl 1-(6-bromopyridin-3-YL)-1-methylethylcarbamate；tert-butyl N-[2-(6-bromopyridin-3-yl)propan-2-yl]carbamate
• CAS: 850197-51-2
• 化学式: C₁₃H₁₉BrN₂O₂
• 分子量: 315.21
• InChiKey: WOYXUGKXBQLLBU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  51.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl (2-(6-bromopyridin-3-yl)propan-2-yl)carbamate 在 1,1'-双(二苯基膦)二茂铁 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 水 、 三乙胺 、 lithium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 20.0~80.0 ℃ 、620.54 kPa 条件下， 反应 17.0h， 生成 5-(2-((tert-butoxycarbonyl)amino)propan-2-yl)picolinic acid
  参考文献：
  名称：

  ADENOSINE A2A AND A2B RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

  摘要：

  In its many embodiments, the invention provides certain substituted amino triazolo quinazoline compounds of the structural Formula (I), and pharmaceutically acceptable salts thereof, wherein, ring A, R1and R2are as defined herein. Also provided are pharmaceutical compositions comprising one or more such compounds, alone or in combination with one or more other therapeutically active agents. Methods for the preparation of the compounds and their use as antagonists of A2a and/or A2b receptors, either alone or in combination with other therapeutic agents, in the treatment of a variety of diseases, conditions, or disorders that are mediated at least in part, by the adenosine A2a receptor and/or the adenosine A2b receptor, are also provided.

  公开号：

  WO2024118460A1
• 作为产物：
  描述：

  二碳酸二叔丁酯 、 2-(6-bromopyridin-3 -yl)propan-2-amine 以 水 为溶剂， 以159 mg的产率得到tert-butyl (2-(6-bromopyridin-3-yl)propan-2-yl)carbamate
  参考文献：
  名称：

  ADENOSINE A2A AND A2B RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

  摘要：

  In its many embodiments, the invention provides certain substituted amino triazolo quinazoline compounds of the structural Formula (I), and pharmaceutically acceptable salts thereof, wherein, ring A, R1and R2are as defined herein. Also provided are pharmaceutical compositions comprising one or more such compounds, alone or in combination with one or more other therapeutically active agents. Methods for the preparation of the compounds and their use as antagonists of A2a and/or A2b receptors, either alone or in combination with other therapeutic agents, in the treatment of a variety of diseases, conditions, or disorders that are mediated at least in part, by the adenosine A2a receptor and/or the adenosine A2b receptor, are also provided.

  公开号：

  WO2024118460A1

文献信息

• Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient
  申请人：Seike Hisayuki

  公开号：US20090012123A1

  公开（公告）日：2009-01-08

  As a result of intensive studies for the purpose of finding a new medicinal use of an indazole derivative, it was found that an indazole derivative inhibits glutamate-induced retinal neuronal cell death in rat fetal retinal neuronal cells, in other words, the indazole derivative acts directly on the retinal neuronal cells and exhibits an effect of protecting retinal neuronal cells. Accordingly, the indazole derivative is useful for the prevention or treatment of an eye disease associated with retinal neuronal cell damage or retinal damage.

  经过对吲唑衍生物进行深入研究，目的是寻找其新的药用价值。研究发现，吲唑衍生物在大鼠胎儿视网膜神经细胞中能够抑制谷氨酸诱导的视网膜神经细胞死亡，换句话说，吲唑衍生物直接作用于视网膜神经细胞，并显示出保护视网膜神经细胞的效果。因此，吲唑衍生物对于预防或治疗与视网膜神经细胞损伤或视网膜损伤相关的眼病是有用的。
• Novel indazole derivatives
  申请人：Hagihara Masahiko

  公开号：US20070129404A1

  公开（公告）日：2007-06-07

  An object of the present invention is to create a novel indazole derivative useful as a drug and to find a novel pharmacological action of the derivative. The compound of the present invention is represented by the formula [I] and has an excellent Rho kinase inhibiting action. In the formula, a ring X is a benzene ring or a pyridine ring; R 1 and R 2 are H or alkyl; R 3 and R 4 are halogen, H, OH, alkoxy, alkenyloxy, alkynyloxy, cycloalkyloxy, cycloalkenyloxy, aryloxy, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, carboxy, hydrocarbonyl, alkylcarbonyl, etc.; and R 5 is halogen atom, H, OH, alkoxy, aryloxy, alkyl or aryl. Each group can be substituted.

  本发明的目的是创建一种新的吲唑衍生物作为药物，并找到该衍生物的新的药理作用。本发明的化合物由公式[I]表示，并具有出色的Rho激酶抑制作用。在公式中，环X是苯环或吡啶环；R1和R2是H或烷基；R3和R4是卤素，H，OH，烷氧基，烯氧基，炔氧基，环烷氧基，环烯氧基，芳氧基，烷基，烯基，炔基，环烷基，环烯基，芳基，羧基，烷基羰基等；而R5是卤素原子，H，OH，烷氧基，芳氧基，烷基或芳基。每个基团都可以被取代。
• PROTECTIVE AGENT FOR RETINAL NEURONAL CELL COMPRISING INDAZOLE DERIVATIVE AS ACTIVE INGREDIENT
  申请人：Ube Industries, Ltd.

  公开号：EP1870099A1

  公开（公告）日：2007-12-26

  As a result of intensive studies for the purpose of finding a new medicinal use of an indazole derivative, it was found that an indazole derivative inhibits glutamate-induced retinal neuronal cell death in rat fetal retinal neuronal cells, in other words, the indazole derivative acts directly on the retinal neuronal cells and exhibits an effect of protecting retinal neuronal cells. Accordingly, the indazole derivative is useful for the prevention or treatment of an eye disease associated with retinal neuronal cell damage or retinal damage.

  为了寻找一种吲唑衍生物的新药用用途而进行的深入研究发现，吲唑衍生物可抑制谷氨酸诱导的大鼠胎儿视网膜神经细胞死亡，换句话说，吲唑衍生物直接作用于视网膜神经细胞，并显示出保护视网膜神经细胞的效果。因此，吲唑衍生物可用于预防或治疗与视网膜神经元细胞损伤或视网膜损伤有关的眼病。
• NOVEL INDAZOLE DERIVATIVE
  申请人：Ube Industries, Ltd.

  公开号：EP1679308B1

  公开（公告）日：2013-07-24
• Methods for treating a disease in which Rho kinase is involved
  申请人：Hagihara Masahiko

  公开号：US20090264468A1

  公开（公告）日：2009-10-22

  A method for treating a disease in which Rho kinase is involved. The method is carried out by administering to a patient in need thereof a pharmaceutically effective amount of a compound of the following formula or a pharmaceutically acceptable salt thereof: , wherein the ring X is a benzene ring or a pyridine ring; R 1 and R 2 are hydrogen or alkyl or together form a cycloalkene ring; R 3 is hydrogen, substituted alkyl, unsubstituted alkenyl, carboxyl or an ester or an amide thereof, amino or a cyano; R 4 is hydrogen, hydroxyl, substituted or unsubstituted alkoxy, unsubstituted alkenyloxy, unsubstituted cycloalkyloxy, substituted or unsubstituted alkyl, unsubstituted alkenyl, unsubstituted cycloalkyl, amino, substituted or unsubstituted alkylamino, nitro, cyano or a monocyclic heterocycle; and R 5 is a halogen atom or a hydrogen atom.